Back

Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: metabolic and mechanistic insights Disease Modelling ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ning Ding

the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an (China)

6 More presentations in this session

Presentation thumbnail
Sex-specific FIND-AF risk thresholds aligned with CMR-defined atrial cardiomyopathy identify excess cardiovascular risk in heart failure across nationwide primary care data
Doctor K. Kazi (Manchester, GB)
Abstract
Presentation thumbnail
Influence of AF burden on NT-proBNP and left ventricular reverse remodeling in patients with AF and HF: catheter ablation versus pharmacological rhythm control
Doctor B. Orazlyyeva (Ashgabat, TM)
Abstract
Presentation thumbnail
Metabolic improvement without structural reverse remodelling in diabetic atrial fibrillation patients receiving lifestyle modification: A post-hoc analysis of the PRAGUE-25 trial
Doctor J. Mohr (Trinec, CZ)
Abstract
Presentation thumbnail
Symptoms and quality of life in individuals with screen-detected atrial fibrillation: insights from the NORSCREEN trial
Mr M. Boskovic (Kristiansand, NO)
Abstract
Presentation thumbnail
Association of diabetes, glycemic status and vascular brain lesions in patients with atrial fibrillation
Ms S. Balasundaram (Basel, CH)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation: metabolic and mechanistic insights

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Gut microbiota and subclinical atherosclerosis: a new emerging perspective.
3 April 2025
thumbnail
Congress Presentation
iPSC-derived cardiomyocytes as a model to dissect ion current alterations of genetic atrial fibrillation
8 July 2016
thumbnail
Congress Presentation
Butyrate infusion improves cardiac performance without aggravating myocardial injury in a porcine model of myocardial ischemic reperfusion
20 March 2026
thumbnail
Congress Presentation
Defining the amino acid profile in patients with atrial fibrillation associated with left heart remodeling.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources